Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 2 of 3: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20257)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | Erlotinib | 10 | uM | 10 | 5000.00 | 2314.91 | 6340.67 | 6560.75 | 0.9665 | 0.9553 |
MDA-MB-231 | Erlotinib | 19.9526 | uM | 10 | 5000.00 | 2314.91 | 5582.67 | 6560.75 | 0.8510 | 0.7963 |
MDA-MB-231 | Lapatinib | 0.0016596 | uM | 10 | 5000.00 | 2314.91 | 6667.33 | 6560.75 | 1.0162 | 1.0214 |
MDA-MB-231 | Lapatinib | 0.0033113 | uM | 10 | 5000.00 | 2314.91 | 6516.67 | 6560.75 | 0.9932 | 0.9906 |
MDA-MB-231 | Lapatinib | 0.01 | uM | 10 | 5000.00 | 2314.91 | 6581.67 | 6560.75 | 1.0032 | 1.0042 |
MDA-MB-231 | Lapatinib | 0.031623 | uM | 10 | 5000.00 | 2314.91 | 6565.67 | 6560.75 | 1.0008 | 1.0010 |
MDA-MB-231 | Lapatinib | 0.1 | uM | 10 | 5000.00 | 2314.91 | 6667.00 | 6560.75 | 1.0163 | 1.0217 |
MDA-MB-231 | Lapatinib | 0.31623 | uM | 10 | 5000.00 | 2314.91 | 6729.67 | 6560.75 | 1.0257 | 1.0340 |
MDA-MB-231 | Lapatinib | 1 | uM | 10 | 5000.00 | 2314.91 | 6632.00 | 6560.75 | 1.0109 | 1.0145 |
MDA-MB-231 | Lapatinib | 3.1623 | uM | 10 | 5000.00 | 2314.91 | 6329.33 | 6560.75 | 0.9648 | 0.9527 |
MDA-MB-231 | Lapatinib | 10 | uM | 10 | 5000.00 | 2314.91 | 5744.00 | 6560.75 | 0.8758 | 0.8307 |
MDA-MB-231 | Omipalisib | 0.0016596 | uM | 10 | 5000.00 | 2314.91 | 4590.67 | 5100.92 | 0.9117 | 0.8901 |
MDA-MB-231 | Omipalisib | 0.0033113 | uM | 10 | 5000.00 | 2314.91 | 4461.00 | 5100.92 | 0.8905 | 0.8600 |
MDA-MB-231 | Omipalisib | 0.01 | uM | 10 | 5000.00 | 2314.91 | 3958.67 | 5100.92 | 0.7918 | 0.6437 |
MDA-MB-231 | Omipalisib | 0.031623 | uM | 10 | 5000.00 | 2314.91 | 3741.67 | 5100.92 | 0.7467 | 0.5304 |
MDA-MB-231 | Omipalisib | 0.1 | uM | 10 | 5000.00 | 2314.91 | 3412.00 | 5100.92 | 0.6963 | 0.4651 |
MDA-MB-231 | Omipalisib | 0.31623 | uM | 10 | 5000.00 | 2314.91 | 2991.00 | 5100.92 | 0.6226 | 0.3079 |
MDA-MB-231 | Omipalisib | 1 | uM | 10 | 5000.00 | 2314.91 | 2512.33 | 5100.92 | 0.5333 | 0.1054 |
MDA-MB-231 | Omipalisib | 3.1623 | uM | 10 | 5000.00 | 2314.91 | 2195.33 | 5100.92 | 0.4757 | -0.0244 |
MDA-MB-231 | Omipalisib | 10 | uM | 10 | 5000.00 | 2314.91 | 1796.00 | 5100.92 | 0.3725 | -0.2697 |
MDA-MB-231 | Nilotinib | 0.0033113 | uM | 10 | 5000.00 | 2314.91 | 5120.67 | 5100.92 | 1.0071 | 1.0342 |
MDA-MB-231 | Nilotinib | 0.01 | uM | 10 | 5000.00 | 2314.91 | 5029.67 | 5100.92 | 0.9892 | 0.9855 |
MDA-MB-231 | Nilotinib | 0.031623 | uM | 10 | 5000.00 | 2314.91 | 5478.33 | 5100.92 | 1.0841 | 1.2322 |
MDA-MB-231 | Nilotinib | 0.1 | uM | 10 | 5000.00 | 2314.91 | 5053.33 | 5100.92 | 0.9954 | 1.0101 |
MDA-MB-231 | Nilotinib | 0.31623 | uM | 10 | 5000.00 | 2314.91 | 4759.00 | 5100.92 | 0.9520 | 0.9648 |